News Daily News Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity L.A. McKeown December 23, 2024
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
Presentation AHA 2024 Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial Presenter: Milton Packer November 16, 2024
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024
News Daily News Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key Todd Neale November 13, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Daily News Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome Caitlin E. Cox October 04, 2024
News Daily News Liraglutide Helps Shed Weight in Young Children With Obesity Todd Neale September 13, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2024 Caitlin E. Cox September 03, 2024
News Daily News Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says Caitlin E. Cox August 28, 2024
News Daily News ‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database Michael O'Riordan August 21, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Daily News Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources Todd Neale August 12, 2024
News Daily News SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results Yael L. Maxwell August 01, 2024